Brady Makes $1.4B Leveraged Acquisition, Shifting from Net Cash to Net Debt

What happened

Brady Corporation, which recently reported strong FQ1’26 results and a net cash balance sheet, has reportedly agreed to a $1.4 billion acquisition at 8x EBITDA. The deal, first noted in a Seeking Alpha article, marks a departure from Brady’s previous pattern of bolt-on acquisitions like Gravotech, AB&R, and Microfluidic Solutions. The purchase likely requires new debt, moving the company from a net cash position to meaningful leverage. While the 8x multiple appears accretive relative to Brady’s own 15x EV/EBITDA, the scale of integration and the addition of financial leverage raise execution risk. This occurs as Brady is already navigating tariff costs, European softness, and elevated R&D spending.

Implication

The move transforms Brady from a low-leverage compounder into a leveraged growth story, which could re-rate the stock if integration succeeds but could also pressure margins and cash flow if the acquired business underperforms. Given Brady’s own guidance for low-single-digit organic growth and tariff headwinds, taking on debt reduces the margin of safety that existed from the net cash balance sheet. The 8x EBITDA multiple suggests the target is cheaper than Brady’s own valuation, but synergies will be critical to justify the price and leverage. Investors should also watch whether the acquisition addresses Europe’s weakness or adds new complexity. Until integration milestones are visible, the previous WAIT rating should be maintained, with a preference for an entry below $82 or after two quarters of stable margins.

Thesis delta

The original WAIT thesis was based on Brady’s premium valuation and the need for Europe and margin stabilization. The reported $1.4B leveraged acquisition adds a new layer of risk, as the company transitions from net cash to net debt and takes on a large integration challenge. While the deal could be accretive, it removes the balance sheet cushion that previously limited downside, warranting an even more cautious stance until the acquisition closes and early integration results are known.